Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Triest, B.
Right arrow Articles by Peters, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Triest, B.
Right arrow Articles by Peters, G. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry, Vol. 48, 755-760, June 2000, Copyright © 2000, The Histochemical Society, Inc.


ARTICLE

Thymidylate Synthase Expression in Patients with Colorectal Carcinoma Using a Polyclonal Thymidylate Synthase Antibody in Comparison to the TS 106 Monoclonal Antibody

Baukelien Van Triesta, Barbara M. Loftusc, Herbert M. Pinedoa, Harold H.J. Backusa, Pascale Schoenmakersa, Frank Tellemana, Thea Tademab, G. Wynne Ahernef, Cornelius J. Van Groeningena, Frans A.N. Zoetmulderd, Babs G. Taale, Patrick G. Johnstong, and Godefridus J. Petersa
a Departments of Medical Oncology, University Hospital VU, Amsterdam, The Netherlands
b Pathology, University Hospital VU, Amsterdam, The Netherlands
c Departments of Pathology, Netherlands Cancer Institute/Antoni Van Leeuwenhoekhuis, Amsterdam, The Netherlands
d Surgery, Netherlands Cancer Institute/Antoni Van Leeuwenhoekhuis, Amsterdam, The Netherlands
e Gastroenterology, Netherlands Cancer Institute/Antoni Van Leeuwenhoekhuis, Amsterdam, The Netherlands
f Department of Drug Development, Cancer Research Campaign, Institute for Cancer Research, Sutton, United Kingdom
g Department Oncology, Queen's University of Belfast, Belfast, United Kingdom

Correspondence to: Godefridus J. Peters, Dept. of Medical Oncology, University Hospital VU, PO 7057, 1007 MB Amsterdam, The Netherlands. E-mail: gj.peters@azvu.nl

Colorectal cancer is one of the most common human cancers, for which 5-fluorouracil (5FU) is usually part of the treatment. Thymidylate synthase (TS), the target enzyme for 5FU, can be predictive for the outcome of 5FU-based therapy. TS levels in tumor samples can be determined with radiochemical enzyme assays, RT-PCR, and immunohistochemical staining. We validated TS immunohistochemistry with a polyclonal rabbit anti-human TS antibody using the avidin–biotin method. This antibody can be used on paraffin-embedded, formalin-fixed material using an antigen retrieval method with citrate buffer and microwave treatment. The antibody shows a granular cytosolic staining pattern. The reproducibility in cross-sections from colorectal tumors from 50 patients was 90% and the interobserver variability was acceptable with a kappa of 0.45. On Western blotting it detects purified TS at 36 kD, while in 5FU-treated cells the ternary complex between FdUMP, TS, and 5,10-methylene-tetrahydrofolate is clearly visible at 38 kD, with no other interfering bands. In a separate set of tumors, immunostaining was compared with enzyme levels; Western blots correlated with enzyme levels. Because both this polyclonal antibody and the monoclonal antibody TS-106 are being used for large-scale studies, we also determined whether they could be used interchangeably. No differences were observed. This polyclonal antibody is specific and gives reproducible results. A study on a larger scale is ongoing to determine the role of TS as a predictive parameter in patients with colorectal cancer treated either with postoperative adjuvant 5FU/levamisole or with surgery only.

Key Words: thymidylate synthase, immunohistochemistry, polyclonal antibody, colorectal cancer


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
J. L. Westra, H. Hollema, M. Schaapveld, I. Platteel, K. A. Oien, W. N. Keith, R. Mauritz, G. J. Peters, C. H. C. M. Buys, R. M. W. Hofstra, et al.
Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients
Ann. Onc., October 1, 2005; 16(10): 1646 - 1653.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. Ohrling, D. Edler, M. Hallstrom, P. Ragnhammar, and H. Blomgren
Detection of Thymidylate Synthase Expression in Lymph Node Metastases of Colorectal Cancer Can Improve the Prognostic Information
J. Clin. Oncol., August 20, 2005; 23(24): 5628 - 5634.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Allegra and D. Sargent
Molecular Diagnostics: Assays, Tissues, Progress, and Pitfalls
J. Clin. Oncol., February 1, 2003; 21(3): 395 - 396.
[Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Derenzini, L. Montanaro, A. Chilla, E. Tosti, C. Ceccarelli, F. Dall'Olio, D. Ofner, and D. Trere
Evaluation of Thymidylate Synthase Protein Expression by Western Blotting and Immunohistochemistry on Human Colon Carcinoma Xenografts in Nude Mice
J. Histochem. Cytochem., December 1, 2002; 50(12): 1633 - 1640.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
H H J Backus, C J Van Groeningen, W Vos, D F Dukers, E Bloemena, D Wouters, H M Pinedo, and G J Peters
Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases
J. Clin. Pathol., March 1, 2002; 55(3): 206 - 211.
[Abstract] [Full Text] [PDF]




Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2000